Complete Scientific Guide to Vitamin C: Chemistry, Evidence, Safety and Quality

Vitamin C is one of the most familiar nutrients in the world and one of the most misunderstood. It prevents scurvy, builds collagen, improves iron absorption and protects cells from oxidative damage. Yet it is also wrapped in myths: that megadoses cure colds, that “natural” always beats synthetic, that more is always better. This complete scientific guide separates what the evidence supports from what marketing claims.

If you are choosing a supplement, advising a client or simply curious, this page gives you one trustworthy reference. It covers chemistry, sources, history, mechanisms, absorption, clinical evidence, safety, quality testing and regulation, with studies you can verify in the reference list. Start with the quick facts, then jump to the section you need. This article is educational and is not a substitute for medical advice.

Executive Summary: Vitamin C Quick Facts

Vitamin C (L-ascorbic acid) is an essential, water-soluble vitamin. Humans cannot make it, so it must come from food or supplements. Its clearest, best-proven roles are preventing and treating scurvy, supporting collagen formation and enhancing the absorption of non-heme iron. Regular supplementation modestly shortens the duration of common colds but does not reliably prevent them in the general population. Evidence for other claims, from heart disease to cancer to sepsis, is mixed or negative in randomized trials.

Quick fact	Detail
Common names	Vitamin C, L-ascorbic acid, ascorbate
Type	Essential water-soluble vitamin
Formula and mass	C6H8O6, 176.12 g/mol, CAS 50-81-7
Deficiency disease	Scurvy
US RDA (adults)	90 mg/day men, 75 mg/day women; smokers need 35 mg more
US upper limit (adults)	2,000 mg/day
Rich food sources	Acerola, guava, amla, red peppers, kiwi, citrus, broccoli, strawberries
Absorption	About 70–90% at 30–180 mg; under 50% above 1,000 mg
Best-supported benefits	Scurvy prevention and cure, iron absorption, modest cold-duration reduction
Main cautions	Kidney stone history, iron overload disorders, dialysis, high-dose IV use in G6PD deficiency

The evidence in brief

• Food first: 200 mg a day from fruit and vegetables saturates plasma levels in most healthy adults.
• Higher supplement doses raise blood levels only slightly, because absorption falls and the kidneys excrete the excess.
• Natural and synthetic ascorbic acid are chemically identical, and studies show similar bioavailability.
• Intakes above 2,000 mg a day commonly cause diarrhea and may raise kidney stone risk.
• Quality varies by brand, so batch testing and honest labelling matter.

What Is Vitamin C? Ingredient Definition and Identity

“Vitamin C” is the nutritional name for compounds that prevent scurvy. In practice it refers mainly to L-ascorbic acid and its reversible oxidized form, dehydroascorbic acid (DHA), which the body can convert back to ascorbate. At body pH, the molecule exists mostly as the ascorbate anion, which is why scientific papers often say “ascorbate” rather than “ascorbic acid.”

The word “essential” has a specific meaning here. Most mammals make their own ascorbate from glucose in the liver or kidney using a final enzyme called L-gulonolactone oxidase (GULO). Humans, other higher primates and guinea pigs carry a broken, non-functional version of the gene, a loss described by Nishikimi and colleagues in 1994. Because of this ancient mutation, our diet must supply what other animals manufacture internally.

Identity matters commercially as well. A genuine vitamin C ingredient must be L-ascorbic acid or one of its recognised salts or esters. The mirror-image D-isomer, known as erythorbic acid or isoascorbic acid, is a food preservative with only a small fraction of vitamin activity and should never be sold as vitamin C.

Chemical and Biological Classification of Vitamin C

Chemical classification. L-ascorbic acid is a six-carbon sugar acid derivative. Structurally it is a five-membered lactone ring (a γ-lactone) bearing an enediol group at carbons 2 and 3, plus a two-carbon dihydroxyethyl side chain. That enediol is the reactive center: it donates electrons easily, which makes ascorbate a powerful reducing agent. Its systematic name is (5R)-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one.

Biological classification. In nutrition science, vitamin C is a water-soluble vitamin, an antioxidant and an enzyme cofactor. It is not stored in large amounts, unlike fat-soluble vitamins A, D, E and K.

Botanical distribution. Vitamin C is not a botanical species but a compound that most plants produce. Rich sources come from several plant families:

• Malpighiaceae: acerola (Malpighia emarginata)
• Phyllanthaceae: amla or Indian gooseberry (Phyllanthus emblica)
• Myrtaceae: guava (Psidium guajava) and camu camu (Myrciaria dubia)
• Rutaceae: orange, lemon, lime and other citrus
• Solanaceae: sweet peppers (Capsicum annuum)
• Actinidiaceae: kiwifruit; Brassicaceae: broccoli; Rosaceae: rose hips and strawberries

Regulatory classification. Ascorbic acid is also a food additive (E300 in Europe), an antioxidant preservative, a pharmaceutical ingredient with USP and European Pharmacopoeia monographs, and, in the United States, a substance generally recognised as safe for use in foods.

Origin, Cultivation and Sources of Vitamin C

How plants make it. Most plants synthesize ascorbate from glucose through the D-mannose/L-galactose pathway described by Smirnoff and Wheeler. The last step happens in the mitochondria, after which the vitamin is distributed throughout the cell. Plants use it to neutralize reactive oxygen formed in photosynthesis, so leaf and fruit levels respond to light intensity, temperature, variety, ripeness and stress.

Food sources. Values from the USDA FoodData Central database illustrate the range per 100 g of raw edible portion:

Food	Approx. vitamin C (mg/100 g)
Acerola cherry	~1,680
Guava	~228
Red sweet pepper	~128
Kiwifruit (green)	~93
Broccoli	~89
Strawberry	~59
Orange	~53

Amla and camu camu are also very rich, though reported values vary widely with cultivar, maturity and analytical method, so treat any single figure with caution.

Cultivation and post-harvest handling. Citrus is grown commercially across Brazil, China, India, the Mediterranean and the United States. Acerola is grown mainly in Brazil and the Caribbean, amla across India, and camu camu in the Amazon basin. Because ascorbate is oxidized by air, heat and enzymes, harvest timing, cold storage and rapid processing strongly influence the final content. Cooking in large volumes of water causes substantial losses through leaching and heat, whereas steaming or microwaving retains more.

Commercial supply. Most vitamin C sold in supplements, fortified foods and beverages is not extracted from fruit. It is manufactured from glucose, typically derived from corn starch, using the processes described in the extraction section below. A smaller market supplies fruit-derived powders such as acerola, amla and camu camu.

History and Traditional Use of Vitamin C

Scurvy in history. Scurvy has been described since antiquity. Crusaders, armies and, above all, sailors suffered from it during long voyages without fresh produce. Symptoms of bleeding gums, bruising, slow wound healing and exhaustion killed very large numbers of seafarers; some historians estimate millions over the age of sail. In 1536 the expedition of Jacques Cartier in Canada was reportedly saved when local Indigenous people offered a tea made from an evergreen tree, likely white cedar.

The first controlled trial. In 1747 the Scottish naval surgeon James Lind divided twelve scurvy patients aboard HMS Salisbury into pairs and gave each pair a different remedy. The pair given oranges and lemons recovered fastest. Lind published his findings in 1753, and the British Navy eventually issued lemon and later lime juice, though the shift to lower-potency limes in the nineteenth century contributed to later outbreaks.

Isolation and synthesis. The Hungarian biochemist Albert Szent-Györgyi isolated a reducing substance he called hexuronic acid from adrenal glands and plants in 1928. By 1932 it was shown to be the anti-scurvy factor and was renamed ascorbic acid. Walter Haworth determined its structure and, with Edmund Hirst and independently Tadeus Reichstein, achieved synthesis in 1933. Szent-Györgyi received the 1937 Nobel Prize in Physiology or Medicine, and Haworth shared the Nobel Prize in Chemistry that year. Industrial production began in the mid-1930s.

The megadose era. In 1970 Linus Pauling’s book Vitamin C and the Common Cold popularised gram-level intake. Subsequent controlled trials, reviewed by the Cochrane Collaboration, did not support the preventive claims, but the debate shaped modern research.

Traditional use. Many traditional systems used vitamin C-rich plants without knowing the vitamin. In Ayurveda, amla (Amalaki) is a classic rasayana, or rejuvenative, ingredient found in Chyawanprash and Triphala. Rose hip tea was a common European winter remedy, and Indigenous Australian and Amazonian communities have long eaten kakadu plum and camu camu. These uses are cultural history, and the benefits attributed to them should be judged by modern evidence.

Modern Nutraceutical Uses of Vitamin C

Today vitamin C is among the most widely taken supplements worldwide. Typical consumer uses include:

• Immune support, especially during cold season or intense physical stress
• Collagen and skin health, since collagen cannot be made properly without ascorbate
• Iron absorption, particularly for people relying on plant-based iron
• Antioxidant support, alone or combined with vitamin E, zinc and other nutrients
• Eye health, as one component of the AREDS formulation for age-related macular degeneration
• Dietary gaps, for example in smokers, older adults or people with restricted diets

Beyond oral supplements, ascorbic acid is used in fortified foods, as a preservative, in topical serums, and in hospital settings as an injectable for scurvy. Supplement marketing often overstates benefits, so the later sections of this guide grade each claim by the quality of evidence behind it.

Chemical Composition of Ascorbic Acid

Pure ascorbic acid is a white to slightly yellow crystalline powder that is odorless and sour. Its main physical and chemical properties are:

Property	Value
Molecular formula	C6H8O6
Molar mass	176.12 g/mol
Melting point	About 190–192 °C, with decomposition
Water solubility	About 33 g per 100 mL at 20 °C
Acid dissociation (pKa)	~4.17 and ~11.6
Specific optical rotation	About +20.5° to +21.5° (aqueous solution)
UV absorbance	Peak near 245 nm in acid, ~265 nm near neutral

Stability. Dry crystalline ascorbic acid is fairly stable when kept cool, dark and sealed. In solution it is vulnerable to oxygen, light, heat, alkaline pH and trace metal ions such as copper and iron, which catalyse oxidation. Ascorbate first loses an electron to form the ascorbyl radical, then loses a second to form dehydroascorbic acid. DHA is unstable at physiological pH and can hydrolyse irreversibly to 2,3-diketogulonic acid, which then breaks down into compounds including oxalate and threonate. This chemistry explains why vitamin C solutions brown over time and why oxalate appears in discussions of kidney stones.

Key Active Compounds Related to Vitamin C

Primary active forms. L-ascorbic acid is the reduced, biologically active vitamin. Dehydroascorbic acid is the oxidized form, which cells can take up through glucose transporters and recycle back to ascorbate. The ascorbyl radical is the short-lived intermediate between them.

Salts and derivatives. Mineral ascorbates (sodium, calcium, magnesium and potassium) deliver ascorbate with a mineral. Ascorbyl palmitate is a fat-soluble ester used as an antioxidant in foods and cosmetics. Stabilised derivatives such as ascorbyl phosphates are mainly used in topical products.

Co-occurring plant compounds. Whole-food sources contain other compounds that travel with vitamin C but are not vitamin C:

• Flavonoids such as hesperidin and rutin, often marketed as “bioflavonoids,” in citrus and rose hips
• Carotenoids and anthocyanins in acerola and berries
• Hydrolysable tannins and ellagitannins in amla and camu camu

These compounds have their own biological activities, but evidence that they meaningfully improve vitamin C absorption in humans is inconsistent. They should be considered additional ingredients rather than proof of a superior product.

Breakdown products. Degradation yields 2,3-diketogulonate, oxalate, threonate and xylose. In the body, oxalate is a normal end product, but high amounts in urine are relevant to stone formation.

Extraction and Processing of Vitamin C

Industrial synthesis. Almost all pure ascorbic acid is produced from D-glucose. In the classical Reichstein process (developed in the 1930s), glucose is hydrogenated to D-sorbitol, fermented by Gluconobacter bacteria to L-sorbose, chemically protected, oxidised to 2-keto-L-gulonic acid, and finally converted to ascorbic acid through acid-catalysed ring closure. A later two-step fermentation route, developed in China, uses mixed microbial cultures to convert sorbose directly to 2-keto-L-gulonic acid, eliminating several chemical steps. This route now supplies the majority of global production.

Purification. The crude product is decolourised with activated carbon, treated with ion-exchange resins, crystallised, dried, milled and sieved to specified particle sizes. Salts are made by neutralising ascorbic acid with sodium, calcium, magnesium or potassium bases.

Fruit-derived powders. Natural vitamin C ingredients are made by pressing or extracting fruit, concentrating the juice (often by membrane filtration or low-temperature evaporation), and drying it by spray-drying or freeze-drying. Carriers such as maltodextrin are commonly added to protect the vitamin and improve flow. The final vitamin C content depends on the fruit, extraction conditions and amount of carrier.

Finishing technologies. Manufacturers may coat particles (for example with ethylcellulose) for sustained release, create liposomal preparations by encapsulating ascorbate in phospholipid vesicles, or granulate the powder with stabilisers for effervescent tablets. Each step must limit exposure to heat, moisture, oxygen and metal contact to avoid degradation.

Standardization and Potency of Vitamin C Products

What potency means. For vitamin C, potency is the amount of ascorbic acid, or ascorbic acid equivalent, per serving. A label should state this in milligrams and specify the source compound, for example “Vitamin C (as calcium ascorbate) 500 mg.” When mineral ascorbates are used, a good label also lists the mineral content, because 1,000 mg of sodium ascorbate delivers about 890 mg ascorbic acid equivalent plus roughly 130 mg of sodium.

Pharmacopoeial standards. The USP and European Pharmacopoeia monographs for ascorbic acid raw material require a purity of about 99.0–100.5% by titration, with limits on heavy metals and residual impurities. Finished tablets are commonly specified at roughly 90–110% of label claim at release, though a brand’s own specification may differ.

Analytical methods. Laboratories measure vitamin C by iodometric or 2,6-dichlorophenolindophenol titration, or more selectively by HPLC with UV detection. Because DHA may contribute to total activity, some methods quantify it after reduction.

Natural extracts. Fruit extracts are standardised differently. Acerola powders are often sold at roughly 17% or 25% vitamin C, and amla extracts may be standardised to vitamin C or to hydrolysable tannins. A product labelled “acerola extract 1,000 mg” may therefore contain far less than 1,000 mg of actual vitamin C. Always look for the vitamin C figure itself.

Stability and shelf life. Potency declines with time, especially in humid, warm storage. Reliable brands test finished products across their shelf life and state expiry dates based on stability data, not on estimates.

Mechanisms of Action of Vitamin C

Vitamin C works in three broad ways: as an electron donor (antioxidant), as an enzyme cofactor, and as a regulator of cell signalling and gene expression.

1. Antioxidant and redox recycling. Ascorbate readily donates electrons to neutralise reactive oxygen and nitrogen species in water-based compartments. It also regenerates vitamin E by reducing the tocopheroxyl radical formed when vitamin E protects cell membranes and lipoproteins. In the process ascorbate becomes the ascorbyl radical, which is relatively unreactive and can be recycled by cellular enzymes using glutathione and NADH.

2. Cofactor for dioxygenases and monooxygenases. Many enzymes need ascorbate to keep their metal centre in the reduced state. Key examples include:

• Prolyl and lysyl hydroxylases, which stabilise collagen. Without ascorbate, collagen is unstable, which explains the bleeding, poor wound healing and fragile vessels of scurvy.
• Dopamine β-hydroxylase, needed to make norepinephrine from dopamine.
• Peptidyl-glycine α-amidating monooxygenase, which activates many neuropeptide hormones.
• Carnitine biosynthesis enzymes, relevant to fatty-acid energy metabolism.
• Hypoxia-inducible factor (HIF) hydroxylases, which control cellular responses to low oxygen.

3. Epigenetic regulation. Ascorbate also supports TET enzymes, which demethylate DNA, and Jumonji-type histone demethylases. Agathocleous and colleagues (2017) showed that ascorbate regulates haematopoietic stem cell function in mice through TET2, an active area of cancer biology research.

4. Iron handling. In the gut, ascorbate reduces ferric iron (Fe3+) to the more absorbable ferrous form (Fe2+) and forms a soluble complex with it, counteracting inhibitors such as phytates and polyphenols (Hallberg et al., 1989).

5. Immune cell function. Neutrophils, lymphocytes and monocytes accumulate ascorbate to concentrations many times higher than plasma. Research reviewed by Carr and Maggini (2017) links it to neutrophil migration, microbial killing, lymphocyte function and the clean clearance of spent immune cells.

6. Pro-oxidant behaviour at pharmacological levels. When blood concentrations reach millimolar levels, as they can after intravenous infusion but not after oral dosing, ascorbate can react with free iron or copper in extracellular fluid to produce hydrogen peroxide. This is the basis of experimental IV vitamin C research in oncology and the reason oral supplement results cannot be extrapolated to IV treatment.

Pharmacokinetics of Vitamin C

Pharmacokinetics describes how the body absorbs, distributes, metabolises and eliminates a compound. For vitamin C, the defining feature is saturable, dose-dependent transport.

Absorption. Ascorbate is taken up in the small intestine by sodium-dependent vitamin C transporter 1 (SVCT1). Dehydroascorbic acid can enter cells through glucose transporters (GLUT1, GLUT3 and GLUT4), where it is rapidly reduced back to ascorbate. At moderate intakes of 30–180 mg a day, absorption is about 70–90%. Above about 1,000 mg in a single dose, it falls below 50% (NIH Office of Dietary Supplements).

Plasma levels. The classic dose–response study by Levine and colleagues (1996) in healthy young adults found that plasma ascorbate rises steeply up to roughly 100 mg a day and then plateaus near 70–80 µmol/L at about 200–400 mg a day. Taking much more barely changes steady-state levels. Padayatty and co-workers (2004) estimated that even large repeated oral doses of several grams cannot push peak plasma above roughly 220 µmol/L, whereas intravenous infusion can reach concentrations around one hundred times higher.

Distribution. Tissue concentrations vary greatly. The adrenal glands, pituitary, brain, eye lens, leukocytes and the liver contain the highest levels, helped by SVCT2, which concentrates ascorbate inside metabolically active cells. A healthy adult at saturating intake holds a body pool of about 1.5 g, according to NIH data.

Elimination. Ascorbate is filtered by the kidneys, but SVCT1 reabsorbs most of it until a threshold is passed. Above that threshold, the excess is excreted unchanged in urine, along with metabolites such as oxalate. Higher intakes cause faster elimination, so the half-life shortens as dose rises.

Deficiency timeline. In the classic Sheffield and Hodges experiments in the 1940s and 1960s, volunteers kept on near-zero vitamin C intake developed signs of scurvy after one to three months, and as little as 10 mg a day was enough to prevent or cure it (Krebs, 1953; Hodges et al., 1969).

Increased turnover. Smoking, infection, inflammation, diabetes and some medicines lower plasma ascorbate or speed its use, which is why the US guideline adds 35 mg a day for smokers.

Vitamin C Bioavailability: Natural vs Synthetic, Liposomal and Buffered Forms

Bioavailability is the fraction of an ingested dose that reaches the bloodstream and tissues in a usable form. For vitamin C, it depends on dose size, timing, the individual’s current status and, to a lesser degree, the form.

Natural versus synthetic. Ascorbic acid is the same molecule regardless of whether it comes from an orange or a fermenter. A review by Carr and Vissers (2013) concluded that the limited human studies show no meaningful difference in bioavailability between synthetic ascorbic acid and food-derived vitamin C. Foods provide other beneficial compounds, but that is a nutrition benefit of the food, not a bioavailability advantage of the vitamin.

Bioflavonoids. Some products claim that adding citrus flavonoids improves absorption. Human studies are small and inconsistent, so this claim is not firmly supported.

Buffered mineral ascorbates. Sodium, calcium and magnesium ascorbates are less acidic and are often better tolerated by people with sensitive stomachs. Absorption of ascorbate itself appears similar, and these forms mainly change gastrointestinal comfort and add mineral content.

Liposomal vitamin C. Small crossover studies, for instance by Davis and colleagues (2016), reported higher plasma levels after liposomal ascorbate than after the same dose of standard ascorbic acid. However, these trials involved few participants and short observation periods, and some were industry-funded. The result is promising but not yet confirmed by large independent studies.

Sustained-release products. Slow-release formulations can lower the peak concentration and extend the time ascorbate remains elevated. Because transport saturates, spreading intake may increase total absorption compared with one large dose.

Factors that influence absorption:

• Dose size: smaller, divided doses are absorbed proportionally better
• Current status: people who are deficient absorb and retain more
• Smoking and inflammation: raise turnover and lower plasma levels
• Body weight and sex: women tend to reach higher plasma levels than men at the same intake
• Genetic variation in SLC23A1 and other transporter genes: may modestly change plasma levels

Preclinical Evidence Summary

Preclinical research, meaning cell culture and animal studies, has defined most of vitamin C’s biological roles, but its findings do not automatically apply to people.

Scurvy and collagen. Guinea pigs and GULO-knockout mice, which cannot make their own ascorbate, reproduce scurvy, confirming the vitamin’s role in collagen, vessel integrity and wound repair.

Antioxidant and inflammatory studies. Cell and animal studies show that ascorbate reduces oxidative damage and supports endothelial function and neutrophil activity. Human trials of antioxidants have often failed to reproduce these benefits, which suggests that cell-culture conditions and doses differ from real physiology.

Cancer models. High-dose ascorbate has been studied extensively in laboratory cancer models. Yun and colleagues (2015) reported that ascorbate selectively killed KRAS and BRAF mutant colorectal cancer cells by targeting a glycolytic enzyme, and Schoenfeld and colleagues (2017) found that pharmacological ascorbate sensitised some lung and brain tumour cells to radiation through peroxide and iron-related mechanisms. These effects occur at concentrations attainable only by injection.

Epigenetic research. Studies in mice show that vitamin C can enhance TET2 activity in blood stem cells and may suppress leukaemia development in some models (Agathocleous et al., 2017).

Interpreting the data. Many preclinical studies use concentrations that oral supplements cannot reach, use cells grown in unusual oxygen conditions, or use animal strains that handle ascorbate differently from people. They generate hypotheses, not recommendations.

Human Clinical Evidence Summary

This section summarises the major human outcomes in order of how well they are supported.

Scurvy. Evidence is conclusive. Controlled depletion and repletion experiments show that low vitamin C causes scurvy and that small amounts cure it. Treatment typically produces rapid improvement in fatigue and bleeding within days. The US FDA approved an injectable ascorbic acid product (Ascor) in 2017 for patients who cannot take it by mouth.

Common cold. The Cochrane review by Hemilä and Chalker (2013) pooled 29 trials with over 11,000 participants. Regular supplementation of at least 200 mg a day did not reduce how often ordinary people caught colds, but it shortened cold duration by about 8% in adults and 14% in children. In people under heavy short-term physical stress, such as marathon runners, skiers and soldiers in subarctic conditions, the risk of catching a cold was roughly halved. Taking vitamin C only after symptoms start has not shown consistent benefit.

Iron absorption. Ascorbic acid taken with a meal can substantially raise absorption of non-heme iron from that meal, with the size of the effect varying by dose and the other foods eaten (Hallberg et al., 1989). Longer-term improvements in iron status in people eating mixed diets are less certain.

Cardiovascular disease. Observational studies often link higher vitamin C intake and blood levels with lower heart disease risk, but those people also eat more fruit and vegetables and have healthier lifestyles. Randomised trials are mostly negative: the Physicians’ Health Study II (Sesso et al., 2008), which gave 500 mg a day for eight years to more than 14,000 men, found no reduction in major cardiovascular events. A meta-analysis of 29 short trials (Juraschek et al., 2012) found an average blood pressure reduction of about 3.8 mmHg systolic and 1.5 mmHg diastolic at a mean dose near 500 mg a day, a modest result from small studies.

Cancer. Large trials of oral vitamin C have not shown prevention benefits. In the 1985 Mayo Clinic trial, 10 g a day by mouth did not help patients with advanced cancer (Moertel et al., 1985). Intravenous ascorbate has been tested in small early-phase studies for safety and symptoms, but it is not an established cancer therapy.

Sepsis and critical illness. Results are discouraging. In CITRIS-ALI (Fowler et al., 2019), intravenous vitamin C did not improve the main organ-failure outcome in sepsis-related respiratory failure, though an exploratory analysis hinted at lower mortality. The larger LOVIT trial (Lamontagne et al., 2022) of 872 patients found a higher rate of death or persistent organ dysfunction at 28 days with IV vitamin C than with placebo, and VICTAS (Sevransky et al., 2021) combining vitamin C, thiamine and hydrocortisone found no benefit.

Eye health. The AREDS trial (2001) tested a combination of 500 mg vitamin C, 400 IU vitamin E, beta-carotene, 80 mg zinc and copper. In people at high risk, it lowered the risk of progression to advanced age-related macular degeneration by about 25% over five years. Because it was a multi-nutrient formula, the effect cannot be attributed to vitamin C alone.

Gout and urate. A meta-analysis of randomised trials (Juraschek et al., 2011) found that vitamin C modestly lowers serum uric acid, but evidence that it prevents gout attacks is limited.

Exercise adaptation. Large doses may blunt some training adaptations. Paulsen and colleagues (2014) found that 1,000 mg vitamin C plus vitamin E reduced some mitochondrial adaptations to endurance training, although performance effects were not clearly established.

Kidney stones. In a prospective Swedish cohort, men taking vitamin C supplements had about twice the risk of kidney stones as non-users (Thomas et al., 2013). This is observational, but it is consistent with the vitamin’s breakdown to oxalate.

Evidence Grading by Outcome

The table below is a plain-language summary of certainty, drawing on randomised trials, meta-analyses and consensus reviews. It is an editorial grading for readers, not an official regulatory classification.

Outcome	Evidence grade	Summary
Preventing and treating scurvy	Strong	Conclusive from controlled depletion and repletion studies
Enhancing non-heme iron absorption	Strong (meal level)	Consistent; long-term effect on iron status less certain
Reducing cold duration with regular use	Moderate	Small, consistent effect; Cochrane review
Preventing colds in the general population	Moderate evidence of no effect	No reduction in incidence
Preventing colds under extreme physical stress	Limited to moderate	Large relative effect in small specific groups
Lowering blood pressure	Limited	Small average reduction; short trials
Preventing cardiovascular events	Moderate evidence of no effect	Large RCTs null
Preventing or treating cancer (oral)	Moderate evidence of no effect	Trials null; IV research ongoing
Sepsis (IV vitamin C)	Moderate evidence of no benefit	LOVIT suggested possible harm
Slowing macular degeneration	Moderate (combination only)	AREDS formula, not vitamin C alone
Lowering uric acid	Limited	Small effect on serum levels
Skin photoprotection and ageing (oral)	Insufficient	Few quality human trials
Cognitive protection	Insufficient	Mostly observational

Vitamin C Dosages Used in Studies

Doses in research vary by orders of magnitude, which is why it is vital to read the dose in context. Typical values from the literature:

Context	Dose studied	Notes
Preventing scurvy	About 10 mg/day	Sheffield and Hodges experiments
Dietary recommendations	75–90 mg/day (US adults)	Meets needs of nearly all healthy people
Plasma saturation	200–400 mg/day	Levine et al., 1996
Regular cold prevention trials	200 mg to 1 g/day	Cochrane review threshold: at least 200 mg
Cold treatment trials	Several grams on day of onset	Inconsistent results
Blood pressure meta-analysis	Mean about 500 mg/day	Short-term trials
AREDS eye formula	500 mg/day	With vitamin E, zinc, copper
Cardiovascular prevention	500 mg/day for 8 years	Physicians’ Health Study II
Cancer, oral	10 g/day	Mayo Clinic trial, no benefit
Sepsis, intravenous	200 mg/kg/day for up to 4 days	CITRIS-ALI and LOVIT
Experimental cancer, intravenous	Often 0.5–1.5 g/kg	Early-phase research only

A key lesson is that the doses with the best evidence of benefit are modest, and those at gram levels often show no extra benefit.

Timing and Use of Vitamin C

There is no single proven best time of day for vitamin C. Practical principles drawn from its pharmacokinetics are:

• Split larger doses. Because transport saturates, taking 500 mg twice a day is likely to deliver more than 1,000 mg once.
• Take it with food if your stomach is sensitive. Ascorbic acid is acidic, and food reduces irritation. Buffered forms may also help.
• Pair with iron-containing meals if your aim is to improve absorption of plant-based iron, rather than taking it separately.
• Regular, not occasional, use. Cold-related benefits in trials came from daily supplementation, not from starting after symptoms.
• Consider timing around exercise. If you train for endurance, very high daily doses may not be ideal during intensive training blocks, though evidence is limited.
• Tell your clinician before tests. High-dose vitamin C can interfere with some glucose meters and laboratory assays, including some urine and stool tests.
• Do not stop suddenly after very high doses. Although rebound scurvy is rare, a gradual reduction is sensible.

Most healthy people meet their needs from diet alone, and supplements are most useful when intake is low or needs are higher.

Available Forms of Vitamin C

Form	Features	Considerations
Ascorbic acid (tablet, capsule, powder)	Cheapest, most studied	Acidic; may upset sensitive stomachs
Sodium ascorbate	Buffered, less acidic	Adds sodium (about 130 mg per 1,000 mg)
Calcium ascorbate	Buffered, adds calcium	Check total mineral intake
Magnesium or potassium ascorbate	Buffered	Less common; check mineral content
Mineral ascorbate blends with metabolites (e.g. branded Ester-C)	Marketed as gentler and better retained	Independent evidence of superiority is limited
Liposomal vitamin C	Encapsulated in phospholipids	Higher plasma levels in small studies; costlier
Sustained-release	Slower delivery	May lower peaks, extend exposure
Ascorbyl palmitate	Fat-soluble ester	Mainly food and cosmetic use; not a primary oral source
Whole-food powders (acerola, amla, camu camu, rose hip)	Provide co-compounds	Vitamin C content may be low and variable
Gummies and chewables	Easy to take	Often contain sugar; accuracy varies
Effervescent tablets	Dissolve in water	May contain sodium, sweeteners or bicarbonate
Intravenous ascorbate	Clinical use only	Pharmaceutical product given by professionals

When choosing a form, start with your goal and tolerance. For most people, plain ascorbic acid or a buffered ascorbate is adequate. More expensive forms should justify their price with independent data.

Safety and Side Effects of Vitamin C

Vitamin C has a wide safety margin, and serious toxicity from food is essentially unknown. Risks arise mainly from high-dose supplements and specific medical conditions.

Upper intake levels. The US Institute of Medicine set a tolerable upper intake level of 2,000 mg a day for adults, based on gastrointestinal effects. Limits for younger people are lower: 400 mg for ages 1–3, 650 mg for ages 4–8, 1,200 mg for ages 9–13 and 1,800 mg for ages 14–18. The European Food Safety Authority has not set a formal upper limit.

Common side effects. Doses above roughly 2 g can cause osmotic diarrhea, nausea, abdominal cramps, bloating and heartburn. These effects usually resolve when the dose is lowered.

Kidney stones. Ascorbate is partly converted to oxalate, which can crystallise in urine. A Swedish cohort found that men who took supplements had about double the risk of kidney stones (Thomas et al., 2013). People with a history of calcium-oxalate stones should avoid high-dose supplements unless a doctor approves.

Iron overload. Because vitamin C boosts iron absorption, people with hemochromatosis or other iron-overload conditions should avoid supplementing it. In people with transfusion-related iron overload who are treated with deferoxamine, high-dose vitamin C has been associated with cardiac complications (Nienhuis, 1981).

G6PD deficiency. Very high-dose intravenous ascorbate has been linked to red blood cell destruction in people with glucose-6-phosphate dehydrogenase deficiency. Screening is standard before IV therapy. Typical oral doses are considered much lower risk.

Dialysis and kidney failure. People with advanced kidney disease can accumulate oxalate, and high-dose vitamin C is generally avoided.

Lab test interference. Vitamin C can cause false readings in some blood glucose meters, urine glucose tests and stool occult blood tests. Tell your clinician if you take supplements before testing.

Intravenous use. IV ascorbate must only be given by trained professionals using pharmaceutical-grade products. The LOVIT trial raised concern that high-dose IV vitamin C may not be harmless in critically ill patients.

Serious reactions are uncommon, but anyone with a medical condition, a planned surgery or a prescription regimen should discuss supplements with a pharmacist or doctor first.

Drug and Supplement Interactions

Interacting agent	Possible effect	Practical advice
Iron supplements	Vitamin C increases absorption	Helpful in deficiency; dangerous in iron overload
Chemotherapy and radiotherapy	Antioxidants could theoretically reduce treatment effect	Discuss with the oncology team before use
Statins plus niacin	An antioxidant combination that included vitamin C blunted HDL-cholesterol rise in one trial (Brown et al., 2001)	Check with a prescriber
Warfarin	Isolated reports of reduced anticoagulant effect at high doses	Keep intake steady; monitor INR if changing doses
Aluminium-containing antacids	Ascorbate can increase aluminium absorption	Avoid combining, especially in kidney disease
Estrogen-containing contraceptives or hormone therapy	High doses may raise estrogen levels in small studies	Mention high-dose use to your prescriber
Deferoxamine	Cardiac complications reported with high-dose vitamin C	Use only under specialist supervision
Vitamin E	Ascorbate regenerates vitamin E; no harm at usual doses	Generally compatible
Zinc, copper and other minerals	No major interaction at usual doses	Mind the total mineral content of combined products
Smoking and alcohol	Lower vitamin C status	Higher dietary intake is advisable

A pharmacist can check your specific medicines. Interactions with high-dose products are more likely than with standard 100–500 mg supplements.

Special Populations

Infants and children. Needs are small, and breast milk or formula usually supplies enough. Children should not take adult-strength supplements without advice, and the lower upper limits above apply. Gummies can be mistaken for sweets, so storage matters.

Pregnancy and breastfeeding. The US RDA is 85 mg a day in pregnancy and 120 mg during lactation for adults. Doses within the upper limit are generally considered safe, but very high doses are not recommended without medical guidance.

Older adults. Intake and plasma levels are often lower with age, particularly in people with restricted diets or chronic illness. Moderate supplementation can help fill gaps, but kidney function and medications should be considered.

Smokers and people exposed to smoke. Smoking increases oxidative stress and lowers plasma vitamin C. The US guidance adds 35 mg a day for smokers.

People with diabetes. Plasma vitamin C tends to be lower in diabetes. Supplements may interfere with some glucose meters, so check your device.

Bariatric surgery and malabsorption. Reduced intake and absorption make deficiency more likely, so clinicians may monitor levels and recommend supplements.

Alcohol use disorder. Poor diet and high turnover contribute to deficiency; scurvy still occurs in people with limited diets in wealthy countries.

Athletes. Needs are not clearly higher, and high doses may blunt some training adaptation. Food sources are preferable for routine training.

People with kidney stones, kidney disease, hemochromatosis or G6PD deficiency. Follow medical advice and generally avoid high-dose supplements, as explained in the safety section.

Quality, Testing and Authentication of Vitamin C Products

A supplement’s label tells you what the brand claims. Testing shows whether the claim is true. A high-quality vitamin C product should be supported by a batch-specific certificate of analysis and, ideally, independent verification. Key tests include:

• Identity. Infrared spectroscopy, specific optical rotation and melting behaviour confirm the compound is L-ascorbic acid and not a look-alike or the D-isomer.
• Assay (potency). HPLC or titration confirms the vitamin C content against the label, both at release and across shelf life.
• Heavy metals. Lead, arsenic, cadmium and mercury are measured by ICP-MS. This matters more for botanical powders such as amla and rose hip, which absorb metals from soil.
• Microbiology. Total aerobic count, yeast and mold, and absence of E. coli and Salmonella.
• Physical quality. Moisture, particle size, disintegration time and appearance. Discolouration to yellow or brown signals degradation.
• Residual solvents and pesticides in plant extracts.

Credible verification. Look for manufacturing under GMP, an accredited laboratory (for example ISO/IEC 17025), and independent programs such as USP Verified or NSF certification. Check the certifier’s own database rather than trusting a badge on the bottle.

Authenticating “natural” claims. Because synthetic and natural ascorbic acid are chemically identical, standard assays cannot tell them apart. Advanced laboratories use stable-carbon isotope ratio analysis, because corn-derived synthetic ascorbic acid carries a different carbon-13 signature from vitamin C made by citrus and most other plants.

Adulteration and Contamination Risks

The following problems are the most relevant for vitamin C products:

• Synthetic spiking. A “100% natural” acerola or amla powder may be boosted with cheap synthetic ascorbic acid to reach a target potency. Isotope testing can detect this.
• Under-dosing and label confusion. Labels may list the weight of fruit extract, not the vitamin C it provides. Gummies and effervescents can also lose potency in storage.
• Dilution with carriers. Maltodextrin and other fillers may be used heavily in fruit powders. Sugar content can be undeclared in chewables.
• Heavy metals and pesticides in botanical raw materials, especially when sourced from contaminated soil or without testing.
• Microbial and mould contamination in humid storage or poorly dried powders.
• Degraded product. Heat, light and moisture break down ascorbic acid, so old or poorly stored stock may contain far less than claimed.
• Counterfeits and grey-market goods. Online marketplaces sometimes carry relabelled or expired products; buy from authorised sellers and check batch and expiry details.
• Misuse of IV products. Compounded injectable vitamin C must meet sterility and endotoxin standards. Non-pharmaceutical products must never be injected.

Buyer protection comes from asking for the batch COA, comparing the vitamin C figure per serving with the claimed dose, and choosing brands that disclose their manufacturers and testing laboratories. For a step-by-step approach to judging mineral supplement quality, see our companion guide on choosing a high-quality zinc supplement, which applies the same principles.

Regulatory Overview

Regulation varies widely, so the notes below are a general orientation and not legal advice. Check the current rules in your market before making claims or launching products.

United States. Vitamin C supplements are regulated as dietary supplements under the Dietary Supplement Health and Education Act of 1994. Brands are responsible for safety and labelling, must follow current good manufacturing practice (21 CFR Part 111), and may make structure-function claims with a required disclaimer but not disease treatment claims. The FDA’s Daily Value for vitamin C is 90 mg. Injectable ascorbic acid for scurvy is a regulated drug.

European Union. Food supplements fall under Directive 2002/46/EC, which lists permitted vitamin C sources including L-ascorbic acid, its sodium, calcium, potassium and magnesium salts and ascorbyl palmitate. Health claims must be authorised under Regulation (EC) 1924/2006. Authorised vitamin C claims include contributing to normal collagen formation, normal immune function, protection of cells from oxidative stress, reduction of tiredness and fatigue, regeneration of the reduced form of vitamin E and increased iron absorption. EFSA (2013) set a population reference intake of 110 mg a day for men and 95 mg for women.

India. Supplements are regulated by the Food Safety and Standards Authority of India (FSSAI) under its health supplement and nutraceutical regulations, which require licensed manufacturing, approved ingredients and compliant labelling, including the FSSAI licence number. The ICMR-NIN 2020 recommended intakes for vitamin C are higher than earlier Indian values; confirm current figures in the official tables.

Other markets. Health Canada requires a natural product number for supplements, and Australia’s TGA regulates them as listed complementary medicines. Many countries also apply the Codex Alimentarius framework for labelling and additives.

Across regions, the common principles are truthful labelling, safe doses, GMP manufacturing and no unproven disease claims.

Research Gaps

Despite decades of study, important questions remain:

• Optimal intake for health outcomes. Dietary reference values are largely based on plasma saturation and deficiency prevention, not on proven disease risk reduction.
• Food versus supplement. Observational benefits may reflect fruit and vegetable intake, and few trials test vitamin C inside whole foods against isolated supplements.
• Form comparisons. Independent, well-powered human trials of liposomal, buffered, sustained-release and fruit-derived products are scarce.
• Individual variation. Genetic variants in vitamin C transporters, and interactions such as the haptoglobin genotype in diabetes, may influence who benefits, but findings are preliminary.
• Intravenous therapy. The role in oncology and critical care remains unsettled, and trial results so far are conflicting.
• Long-term and special-population data. More research is needed in pregnancy, ageing, chronic disease and people with low baseline status.
• Standardised reporting. Many trials do not report the form, source or batch testing of the vitamin C they used, which limits comparison.

Frequently Asked Questions About Vitamin C

How much vitamin C do I need each day?

The US recommended dietary allowance is 90 mg for adult men and 75 mg for adult women, with 35 mg more for smokers. Other countries set somewhat different values. Most healthy people meet these amounts through fruit and vegetables.

Does vitamin C prevent colds?

Not in the general population. Regular intake of at least 200 mg a day modestly shortens colds, by about 8% in adults and 14% in children according to the Cochrane review, but it does not reliably reduce how often you catch them.

Is natural vitamin C better than synthetic?

The molecules are identical, and studies show similar bioavailability. Whole foods offer other nutrients, which is a reason to eat them, not evidence that synthetic ascorbic acid is inferior.

What is the best form of vitamin C?

There is no single best form. Plain ascorbic acid is the most studied and economical. Buffered ascorbates suit sensitive stomachs. Liposomal and branded forms may be useful but need stronger independent evidence.

Can I take too much vitamin C?

Yes. The adult upper limit is 2,000 mg a day. Higher intakes commonly cause diarrhea and may increase kidney stone risk, particularly in men and people with a stone history.

When is the best time to take vitamin C?

There is no proven ideal time. Splitting larger doses, taking it with food if your stomach is sensitive, and taking it with iron-containing meals if you want better iron absorption are sensible approaches.

Does vitamin C help skin?

Vitamin C is essential for collagen synthesis, and severe deficiency damages skin and wound healing. In people with adequate intake, evidence that oral supplements improve skin appearance is limited. Topical formulations have a separate evidence base.

Can vitamin C interact with medicines?

Yes, though most interactions occur at high doses. Examples include iron-overload treatments, chemotherapy, warfarin, some antacids and certain cholesterol regimens. Ask your pharmacist or doctor.

Is intravenous vitamin C a proven treatment?

Intravenous vitamin C is proven only for treating scurvy when oral intake is not possible. For cancer and sepsis, the evidence is inconclusive or negative so far, and it should only be used within clinical supervision or trials.

How can I tell if a vitamin C supplement is good quality?

Check that the label states the vitamin C amount per serving and the compound used, look for a batch-specific certificate of analysis showing potency, heavy metals and microbial results, and prefer products verified by an independent program.

Scientific References

1. Agathocleous M, et al. Ascorbate regulates haematopoietic stem cell function and leukaemogenesis. Nature. 2017;549:476–481.
2. AREDS Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–1436.
3. Brown BG, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345(22):1583–1592.
4. Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211.
5. Carr AC, Vissers MCM. Synthetic or food-derived vitamin C—are they equally bioavailable? Nutrients. 2013;5(11):4284–4304.
6. Davis JL, et al. Liposomal-encapsulated ascorbic acid: influence on vitamin C bioavailability and capacity to protect against ischemia–reperfusion injury. Nutr Metab Insights. 2016;9:25–30.
7. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on dietary reference values for vitamin C. EFSA Journal. 2013;11(11):3418.
8. Fowler AA 3rd, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322(13):1261–1270.
9. Hallberg L, Brune M, Rossander L. The role of vitamin C in iron absorption. Int J Vitam Nutr Res Suppl. 1989;30:103–108.
10. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;(1):CD000980.
11. Hodges RE, et al. Experimental scurvy in man. Am J Clin Nutr. 1969;22(5):535–548.
12. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academies Press; 2000.
13. Juraschek SP, et al. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;95(5):1079–1088.
14. Juraschek SP, Miller ER 3rd, Gelber AC. Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials. Arthritis Care Res. 2011;63(9):1295–1306.
15. Krebs HA. The Sheffield experiment on the vitamin C requirement of human adults. Proc Nutr Soc. 1953;12:237–246.
16. Lamontagne F, et al. Intravenous vitamin C in adults with sepsis in the intensive care unit. N Engl J Med. 2022;386(25):2387–2398.
17. Levine M, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA. 1996;93(8):3704–3709.
18. Lind J. A Treatise of the Scurvy. Edinburgh: Sands, Murray and Cochran; 1753.
19. Moertel CG, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. N Engl J Med. 1985;312(3):137–141.
20. National Institutes of Health, Office of Dietary Supplements. Vitamin C: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/
21. Nienhuis AW. Vitamin C and iron. N Engl J Med. 1981;304:170–171.
22. Nishikimi M, et al. Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man. J Biol Chem. 1994;269(18):13685–13688.
23. Padayatty SJ, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533–537.
24. Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Dis. 2016;22(6):463–493.
25. Paulsen G, et al. Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial. J Physiol. 2014;592(8):1887–1901.
26. Schoenfeld JD, et al. O2•− and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell. 2017;31(4):487–500.
27. Sesso HD, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial. JAMA. 2008;300(18):2123–2133.
28. Sevransky JE, et al. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA. 2021;325(8):742–750.
29. Smirnoff N, Wheeler GL. Ascorbic acid in plants: biosynthesis and function. Crit Rev Biochem Mol Biol. 2000;35(4):291–314.
30. Thomas LD, et al. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med. 2013;173(5):386–388.
31. U.S. Department of Agriculture. FoodData Central. https://fdc.nal.usda.gov
32. U.S. Food and Drug Administration. Current Good Manufacturing Practice for Dietary Supplements, 21 CFR Part 111. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111
33. Yun J, et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. 2015;350(6266):1391–1396.
34. United States Pharmacopeia and European Pharmacopoeia. Ascorbic Acid monographs; Directive 2002/46/EC; Regulation (EC) No 1924/2006; Food Safety and Standards Authority of India, health supplement and nutraceutical regulations.